USA - NASDAQ:THRN - US8852601090 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to THRN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-10-11 | Evercore ISI Group | Downgrade | Outperform -> Neutral |
| 2023-08-30 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-08-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-04-04 | Canaccord Genuity | Maintains | Buy |
| 2022-11-17 | Canaccord Genuity | Initiate | Buy |
| 2022-11-11 | RBC Capital | Maintains | Outperform |
| 2022-08-11 | RBC Capital | Maintains | Outperform |
| 2022-08-11 | Cowen & Co. | Maintains | Outperform |
| 2021-10-18 | RBC Capital | Initiate | Outperform |
| 2021-10-18 | Cowen & Co. | Initiate | Outperform |
| 2021-10-18 | Evercore ISI Group | Initiate | Outperform |
| 2021-10-18 | B of A Securities | Initiate | Buy |
10 analysts have analysed THRN and the average price target is 8.61 USD. This implies a price decrease of -15.52% is expected in the next year compared to the current price of 10.19.
The consensus rating for THORNE HEALTHTECH INC (THRN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering THORNE HEALTHTECH INC (THRN) is 10.